119 related articles for article (PubMed ID: 11119967)
21. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
22. Resolution of hyperparathyroidism associated with immunosuppressive therapy.
Jassal SV; Bargman JM
Clin Nephrol; 1998 Nov; 50(5):326-9. PubMed ID: 9840322
[TBL] [Abstract][Full Text] [Related]
23. Blood parathormone levels and sensitivity of parathyroid glands to hypercalcaemia after successful renal transplantation.
Bernheim J; Touraine JL; Labeeuw M; Pozet N; Traeger J
Proc Eur Dial Transplant Assoc; 1976; 12():477-82. PubMed ID: 778840
[No Abstract] [Full Text] [Related]
24. Risk factors of post renal transplant hyperparathyroidism.
Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of severe uremic hyperparathyroidism using a method for percutaneous injection of the parathyroid glands with ethanol].
Niemczyk S; Elwerowski M; Matuszkiewicz-Rowińska J; Sitkowska-Kurzec Z; Sokalski A; Dziecioł-Jastrzebska M; Gomółka M; Kulicki P; Karolak B; Przedlacki J
Pol Arch Med Wewn; 1999 Feb; 101(2):139-43. PubMed ID: 10723228
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
27. [Changes in serum intact parathyroid hormone levels and ultrasonic findings after percutaneous ethanol injection therapy in a patient with primary hyperparathyroidism].
Soma R; Takayama Y; Mimo T
Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):53-64. PubMed ID: 7895865
[TBL] [Abstract][Full Text] [Related]
28. The diagnosis and treatment of hyperparathyroidism after renal homotransplantation.
Geis WP; Popovtzer MM; Corman JL; Halgrimson CG; Groth CG; Starzi TE
Surg Gynecol Obstet; 1973 Dec; 137(6):997-1010. PubMed ID: 4586351
[No Abstract] [Full Text] [Related]
29. Hypercalcemia after renal transplantation.
Schwartz GH; David DS; Riggio RR; Saville PD; Whitsell JC; Stenzel KH; Rubin AL
Am J Med; 1970 Jul; 49(1):42-51. PubMed ID: 4914475
[No Abstract] [Full Text] [Related]
30. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
31. Tertiary hyperparathyroidism after renal transplantation--report of two cases and comparative study of parathyroid function with secondary hyperparathyroidism in chronic renal failure.
Uchida H; Andoh Y; Tomikawa S; Nishimura Y; Nagano T; Ichikawa N; Kikuchi K; Nomura Y; Degawa T; Meigata K
Transplant Proc; 1994 Aug; 26(4):2167-9. PubMed ID: 8066711
[No Abstract] [Full Text] [Related]
32. Total parathyroidectomy for post-transplantation hyperparathyroidism.
McCarron DA; Lenfesty B; Thier A; Vetto M; Barry J; Krutzik S; Bennett WM
Proc Clin Dial Transplant Forum; 1980; 10():51-5. PubMed ID: 6810353
[No Abstract] [Full Text] [Related]
33. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.
Fletcher S; Kanagasundaram NS; Rayner HC; Irving HC; Fowler RC; Brownjohn AM; Turney JH; Will EJ; Davison AM
Nephrol Dial Transplant; 1998 Dec; 13(12):3111-7. PubMed ID: 9870475
[TBL] [Abstract][Full Text] [Related]
34. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
[TBL] [Abstract][Full Text] [Related]
35. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
[TBL] [Abstract][Full Text] [Related]
36. Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus.
Gallagher H; Kwan JT; Andrews PA
Nephrol Dial Transplant; 2000 Jun; 15(6):928-30. PubMed ID: 10831670
[No Abstract] [Full Text] [Related]
37. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
Nakamura M; Tanaka K; Marui Y; Tomikawa S
Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
[TBL] [Abstract][Full Text] [Related]
38. Ultrasonically guided percutaneous ethanol injection to parathyroid autografts for recurrent hyperparathyroidism.
Takeda S; Michigishi T; Takazakura E
Nephron; 1993; 65(4):651-2. PubMed ID: 8302433
[No Abstract] [Full Text] [Related]
39. [Percutaneous alcohol injection in hyperparathyroidism. Experience in 11 cases with an 18-month follow-up].
Lemmi A; Baroni M; Malaspina C; Rizzo F; Biscarini G; Filipponi P; Gubbiotti G
Radiol Med; 1994 Dec; 88(6):840-3. PubMed ID: 7878245
[TBL] [Abstract][Full Text] [Related]
40. Immunoperoxidase confirmation of ultrasonically guided fine needle aspirates in patients with recurrent hyperparathyroidism.
Sardi A; Bolton JS; Mitchell WT; Merritt CR
Surg Gynecol Obstet; 1992 Dec; 175(6):563-8. PubMed ID: 1448738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
